SCHEMBL1875610

SCHEMBL1875610

CSCCc1c(C(=O)O)cc(C(C)C)n1Cc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.46
FOLH1 Q04609 1/20 0.43
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
HSD17B10 Q99714 1/20 0.39
FABP4 P15090 1/20 0.39
FPR1 P21462 1/20 0.38
CCR2 P41597 1/20 0.37
TSHR P16473 2/20 0.37
LMNA P02545 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HTT P42858 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA3 P07451 1/20 0.36
CA4 P22748 1/20 0.36
CA6 P23280 1/20 0.36
CA7 P43166 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1889109 0.88 MAPT (0.43) FOLH1KDM4EALDH1A1GAATSHR
SCHEMBL1884573 0.84 NOTUM (0.47) NOTUM
SCHEMBL1884680 0.83 NOTUM (0.51) NOTUMKDM4EALDH1A1GAAHSD17B10
SCHEMBL1887819 0.83 NOTUM (0.51) NOTUMKDM4EALDH1A1GAAHSD17B10
SCHEMBL12672207 0.82 NOTUM (0.49) NOTUMKDM4EALDH1A1GAAHSD17B10
SCHEMBL1883652 0.80 S1PR3 (0.57)
SCHEMBL1881262 0.79 NOTUM (0.45) NOTUMFOLH1KDM4EALDH1A1GAA
SCHEMBL1873898 0.77 NOTUM (0.54) NOTUMKDM4EALDH1A1GAAHSD17B10
SCHEMBL1875953 0.77 NOTUM (0.70) NOTUMKDM4EALDH1A1GAAHSD17B10
SCHEMBL1887533 0.72 MAPK8 (0.50) KDM4EALDH1A1GAATSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110105567-A1 Pyrrole Compounds Having Sphingosine-1-Phosphate Receptor Agonist Or Antagonist Biological Activity ALLERGAN, INC. (US) 2011-05-05 US disclosed
EP-2185506-A1 PYRROLE COMPOUNDS HAVING SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST OR ANTAGONIST BIOLOGICAL ACTIVITY Allergan, Inc. (US) 2010-05-19 EP disclosed
WO-2009026407-A1 PYRROLE COMPOUNDS HAVING SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST OR ANTAGONIST BIOLOGICAL ACTIVITY ALLERGAN, INC. (US) 2009-02-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110105567-A1 Pyrrole Compounds Having Sphingosine-1-Phosphate Receptor Agonist Or Antagonist Biological Activity S1PR1, S1PR2, S1PR3 NOTUM 822/4885FOLH1 662/4885KDM4E 3350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.